Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open, Randomized, Controlled Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for Pegylated Recombinant Human Granulocyte Colony Stimulating Factor

NCT05409547 is registered in ClinicalTrials.gov with Ning Huang as lead sponsor.

NCT NCT05409547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open, Randomized, Controlled Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for Pegylated Recombinant Human Granulocyte Colony Stimulating Factor
Lead sponsor
Ning Huang
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2022
Completion date
April 30, 2025
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

granulocyte colony-stimulating factor, stem cell mobilization